iShares BIC 50
Emerging markets companies
Details
ETF description
The iShares BIC 50 ETF is designed to provide investors with targeted exposure to a diversified portfolio of 50 large‑cap companies that are selected based on a blend of best‑in‑class criteria. By tracking the BIC 50 index, this ETF focuses on high‑quality, leading companies with strong market positions and robust financial performance, aiming to deliver potential growth and stability.
Issuer details
iShares ETFs are issued and managed by BlackRock, the world’s largest asset management company.
With 800+ products globally and over $2trn in assets (as at June 2024), iShares ETFs are a flexible, low‑cost way for investors to gain exposure to various market segments, including fixed income, emerging markets and broad‑based indexes.
Index details
The BIC 50 index offers targeted exposure to 50 leading biotechnology companies, capturing the performance and innovation within the biotech sector. By focusing on firms with significant market influence and growth potential, the index provides investors with a concentrated view of the biotechnology industry. It serves as a benchmark for evaluating sector performance and a tool for investors interested in the advancements and opportunities within biotechnology.
This ETF is in collections:
Key information
ETF Breakdown
Please try a different search.
Why InvestEngine
Unbeatable value
Here's how we're able to do it
Choice of 700+ ETFs
View our ETF range